Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares 0-5 Year ... The chart below shows the one year price ...

The recent KHC share price of $28.92 represents a price-to-book ratio of 0.7 and an annual dividend yield of 5.5% ...

Below is a dividend history chart for RY.PRN, showing historical dividend payments on Royal Bank of Canada (Montreal, Quebec)'s Non-Cumulative 5-Year Rate Reset First Preferred Shares, Series AN ...

While not a mind-blowing move, it is good to see that the NeoGenomics, Inc. (NASDAQ:NEO) share price has gained 10% in the last three months. But don't envy holders -- looking back over 5 years ...

But other stock charts look similar with solid earnings ... of the last 4 quarters but has only missed 4 times in the last 5 years. Earnings for Skechers are expected to rise 21.5% in 2024 and ...

Shares of work management software company Atlassian (NASDAQ: TEAM ... it says it now expects full-year revenue growth of 18.5% to 19%, compared with its Q1 guidance of 16.5% to 17% growth.

In trading on Monday, shares of Vornado Realty Trust's 5.25% Series M Cumulative Redeemable Preferred Shares (Symbol: VNO.PRM) were yielding above the 7.5% mark based on its quarterly dividend ...

Total earnings of these companies are up 10.8% year over year on 5.5% higher revenues ... re reported with our Earnings ESP Filter. The chart below shows the price performance of five stocks ...

Late last year, ConocoPhillips completed the Marathon ... company’s shares are somewhat expensive on a relative basis, with the current 5.11X trailing 12-month Enterprise Value/Earnings before ...

With just a day of trading left this month, the three major stock indexes — the Dow, the S&P 500 and the Nasdaq ... chart below shows the price performance of our five picks in the past year.

For example, the recent ES share price of $57.68 represents a price-to-book ratio of 1.4 and an annual dividend yield of 5.22% — by comparison ... and favorable long-term multi-year growth ...

Biotechnology company Moderna Inc. (NASDAQ ... ended 2024 with $9.5 billion in cash. On January 13, 2025, Moderna provided a business update and also lowered full-year 2025 forecasts below ...